Endocrinology and Metabolism10.3803/enm.2015.30.3.2722015303272Efficacy of a Once-Monthly Pill Containing Ibandronate and Cholecalciferol on the Levels of 25-Hydroxyvitamin D and Bone Markers in Postmenopausal Women with OsteoporosisIn-Jin Cho, Ho-Yeon Chung, Sung-Woon Kim, Jae-Won Lee, Tae-Won Lee, Hye-Soon Kim, Sin-Gon Kim, Han Seok Choi, Sung-Hee Choi, Chan Soo Shin, Ki-Won Oh, Yong-Ki Min, Jung-Min Koh, Yumie Rhee, Dong-Won Byun, Yoon-Sok Chung, Jeong Hyun Park, Dong Jin Chung, Minho Shong, Eun-Gyoung Hong, Chang Beom Lee, Ki Hyun Baek, Moo-Il Kang,,
Maturitas10.1016/j.maturitas.2017.03.1422017100158A monthly combined agent of ibandronate and cholecalciferol is effective in bone metabolism but not in muscle strength and bone mineral density in Korean postmenopausal women with osteoporosisSang Ho Yoon,
International Journal of Rheumatic Diseases10.1111/j.1756-185x.2009.01413.x2009123216-224Impact of bone marker feedback on adherence to once monthly ibandronate for osteoporosis among Asian postmenopausal women THE BonAdASIA STUDY GROUP,
Yearbook of Endocrinology10.1016/s0084-3741(08)70152-520072007331-333Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE studyB.L. Clarke,
Bone10.1016/j.bone.2009.03.383200944S433Compliance, persistence and patient satisfaction in 150 mg once-monthly oral ibandronate treated patients with postmenopausal osteoporosis — A non-interventional studyH. Börst, D. Felsenberg, J. Glaab, O. Bock,
Archives of Osteoporosis10.1007/s11657-017-0306-72017121Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal womenAkram Kharroubi, Elias Saba, Riham Smoom, Khaldoun Bader, Hisham Darwish,,
Endocrine Practice10.1016/s1530-891x(20)44061-320061245Abstract #314: Once-Monthly Ibandronate in Postmenopausal Osteoporosis: Two-Year Efficacy and Safety Data from MOBILEMichael A. Bolognese, Mone Zaidi, Keith E. Friend, E. Michael Lewiecki,
Clinical Interventions in Aging10.2147/cia.s443952013597Early changes in 25-hydroxyvitamin D levelsand bone markers after monthly risedronatewith cholecalciferol in Korean patients with osteoporosisHoyeon Chung, Koo, Kwon, Kang, Moon, Jin-Young Park, Shin, Yoon, Yoon, Chang, Yoon-Sok Chung, Park
Bone10.1016/j.bone.2010.03.00320104661626-1632Regional distribution of spine and hip QCT BMD responses after one year of once-monthly ibandronate in postmenopausal osteoporosisKlaus Engelke, Thomas Fuerst, Gorana Dasic, Richard Y. Davies, Harry K. Genant,
Clinical Therapeutics10.1016/j.clinthera.2006.04.0062006284475-490Once-monthly Ibandronate for postmenopausal Osteoporosis: Review of a new dosing regimenEunice Y. Pyon,